3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
2
Neoplasms
1
Cardiovascular Diseases
1
Interventions
Gonadotropin-Releasing Hormone
3
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
Nutrition Assessment
2
palbociclib
1
beta Carotene
1
Vitamin E
1
Testosterone
1
Standard of Care
1
Social Determinants of Health
1
Simvastatin
1
Rosuvastatin Calcium
1
Rivaroxaban
1
Resistance Training
1
Pravastatin
1
Practice Guidelines as Topic
1
Nutritional Status
1
Lysine Acetyltransferase 5
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
Health Information Exchange
1
Geritol
1
Exercise
1
Atorvastatin
1
Ascorbic Acid
1
Angiotensin-Converting Enzyme Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiovascular Diseases
×
Hydroxymethylglutaryl-CoA Reductase Inhibitors
×
Genitourinary
×
Clear all
NCT03127631
2025-01-31
RADICALPC
McMaster University
Phase NA
Recruiting
6,000 enrolled